News

The image shows both company logos of Indica Labs and Source LDPath showcasing the partnership. Since deploying HALO AP® at its Nottingham headquarters, Source BioScience has processed approximately 78,000 cases and 278,000 slides in under nine months with a national rollout now underway that will significantly expand digital pathology capacity across the UK’s outsourced histopathology market.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom

HALO AP, News, Press Releases / , , , ,

Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has demonstrated how an interoperable, scanner-agnostic enterprise platform can eliminate one of the greatest barriers to large-scale digital pathology outsourcing while enabling rapid laboratory growth.

Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom Read More »

Image of the user interface of the ADC Target Scoring module for the HALO image analysis platform, showing analysis results, interactive markup image, spatial analysis overlay image, and proximity histogram.

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development

ADC Target Scoring, HALO, HALO Modules, News, Press Releases / , , ,

Albuquerque, NM, July 30, 2026 – Indica Labs today announces the launch of the HALO® ADC Target Scoring module, a powerful new functionality that supports the development of next-generation precision oncology therapies through quantitative target scoring and spatial analysis.

Indica Labs Introduces the HALO® ADC Target Scoring Module, Advancing Antibody-Drug Conjugate Development Read More »

HALO® ADC Target Scoring Module Features and Functionalities

ADC Target Scoring Module, ADC Target Scoring Module, ADC Target Scoring Module, Blogs, HALO, HALO Modules, HALO Modules, Life Sciences, News / , ,

We’re excited to announce the launch of our new ADC Target Scoring module, designed to support continuous quantitative measurement of target protein expression across different cellular compartments.

HALO® ADC Target Scoring Module Features and Functionalities Read More »

New zero-click preprocessing automatically identifies invasive carcinoma and excludes DCIS, LCIS, and control tissue before ER, PR, HER2, and Ki67 quantification. Shown here is the HALO Breast IHC AI out put of a stained HER2 slide with AI overlay only in the regions of invasive cancer.

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis

HALO AP, News, Press Releases / , , , , , , ,

Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast biomarker quantification suite, seamlessly deployed in HALO AP®. This enhanced new version introduces fully automated identification and exclusion of positive control tissue, ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), and areas of benign tissue prior to biomarker analysis. This zero-click preprocessing and tissue classification workflow represents a critical step in ensuring accurate and reproducible AI outputs.

Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis Read More »

Free Demo
Free Demo
Scroll to Top